Il y a eu 31 transactions d'initiés récentes enregistrées pour Intensity Therapeutics, Inc. (INTS), dont 23 achats et 6 ventes. Le total des achats d'initiés s'élève à $4.89M et le total des ventes d'initiés à $1.78M.
Les initiés notables ayant une activité récente comprennent Bender Lewis H, Talamo Joseph, Wesolowski John M. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — INTS
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-26 |
Bender Lewis H |
President and CEO |
Attribution de RSU |
37,749 |
$6.11 |
$230.65K |
118,549 |
| 2025-12-31 |
Talamo Joseph |
Chief Financial Officer |
Attribution de RSU |
14,482 |
$0.26 |
$3.79K |
28,661 |
| 2025-12-31 |
Wesolowski John M |
Principal Accounting Officer |
Attribution de RSU |
8,918 |
$0.26 |
$2.34K |
85,354 |
| 2025-06-30 |
Talamo Joseph |
Chief Financial Officer |
Attribution de RSU |
14,179 |
$0.26 |
$3.7K |
14,179 |
| 2025-06-30 |
Wesolowski John M |
Principal Accounting Officer |
Attribution de RSU |
69,745 |
$0.26 |
$18.2K |
76,436 |
| 2025-05-02 |
Dubin Thomas I H |
Director |
Attribution de RSU |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2025-05-02 |
Bender Lewis H |
10 Percent Owner, Officer: President and CEO |
Attribution de RSU |
700,000 |
$0.57 |
$399K |
700,000 |
| 2025-05-02 |
Goldberg Mark A |
Director |
Attribution de RSU |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2025-05-02 |
Talamo Joseph |
Chief Financial Officer |
Attribution de RSU |
300,000 |
$0.57 |
$171K |
300,000 |
| 2025-05-02 |
Leahy Emer |
Director |
Attribution de RSU |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2025-05-02 |
Wesolowski John M |
Principal Accounting Officer |
Attribution de RSU |
100,000 |
$0.57 |
$57K |
100,000 |
| 2025-05-02 |
Donovan Daniel |
Director |
Attribution de RSU |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2024-10-21 |
Talamo Joseph |
Chief Financial Officer |
Attribution de RSU |
427,379 |
$3.44 |
$1.47M |
427,379 |
| 2024-10-21 |
Wesolowski John M |
Principal Accounting Officer |
Attribution de RSU |
70,028 |
$3.44 |
$240.9K |
70,028 |
| 2024-06-05 |
Wesolowski John M |
Principal Accounting Officer |
Exercice d'Options |
1,000 |
$4.00 |
$4K |
6,691 |
| 2024-05-14 |
Dubin Thomas I H |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-05-14 |
Dubin Thomas I H |
Director |
Attribution de RSU |
50,000 |
$4.42 |
$221K |
50,000 |
| 2024-03-06 |
Bender Lewis H |
10 Percent Owner, Officer: President and CEO |
Attribution de RSU |
33,574 |
$5.19 |
$174.25K |
33,574 |
| 2024-03-06 |
Goldberg Mark A |
Director |
Attribution de RSU |
50,000 |
$5.19 |
$259.5K |
50,000 |
| 2024-03-06 |
Leahy Emer |
Director |
Attribution de RSU |
50,000 |
$5.19 |
$259.5K |
50,000 |
| 2024-03-06 |
Wesolowski John M |
See Remarks |
Attribution de RSU |
25,000 |
$5.19 |
$129.75K |
25,000 |
| 2024-03-06 |
Donovan Daniel |
Director |
Attribution de RSU |
50,000 |
$5.19 |
$259.5K |
50,000 |
| 2023-12-11 |
Talamo Joseph |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-12-11 |
Talamo Joseph |
Chief Financial Officer |
Attribution de RSU |
80,000 |
$6.88 |
$550.4K |
80,000 |
| 2023-07-19 |
Wesolowski John M |
Interim CFO |
Attribution de RSU |
50,000 |
$6.43 |
$321.5K |
50,000 |
| 2023-06-29 |
Bender Lewis H |
10 Percent Owner, Officer: President and CEO |
Cession |
75,000 |
$11.50 |
$862.5K |
- |
| 2023-06-29 |
Goldberg Mark A |
Director |
Cession |
25,000 |
$11.50 |
$287.5K |
- |
| 2023-06-29 |
Ahlers James M |
Executive VP of Cf |
Cession |
5,000 |
$9.00 |
$45K |
- |
| 2023-06-29 |
Leahy Emer |
Director |
Cession |
25,000 |
$11.50 |
$287.5K |
- |
| 2023-06-29 |
Wesolowski John M |
Interim CFO |
Cession |
6,500 |
$11.50 |
$74.75K |
- |
| 2023-06-29 |
Donovan Daniel |
Director |
Cession |
25,000 |
$9.00 |
$225K |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
